Litigation

Recent Posts

AstraZeneca Paying $68.5 Million In Seroquel Settlement
Posted on 12 Mar 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) AstraZeneca will pay $68.5 million as part of a multistate settlement over allegations that the drug developer promoted its blockbuster psychiatric drug Seroquel for insomnia, Alzheimer's and other unapproved uses. The New... Read More

Tags: off-label use , AstraZeneca , New Jersey , New Jersey Attorney General , Litigation , lawsuit , blockbuster drug , Seroquel , antipsychotic drug

AstraZeneca Pays States $68.5M For Off-Label Marketing Of Seroquel Antipsychotic
Posted on 11 Mar 2011 by Tom Moylan

TRENTON, N.J. - (Mealey's) AstraZeneca Pharmaceuticals L.P. and AstraZeneca L.P. on March 10 agreed to pay $68.5 million to 37 states and the District of Columbia to resolve allegations in a New Jersey state court lawsuit that it marketed its atypical... Read More

Tags: off-label use , Dow v. AstraZeneca , Risperdal , AstraZeneca , New Jersey Attorney General , Litigation , Zyprexa , Seroquel , antipsychotic drug